These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38913646)

  • 1. Combination of sarcopenia and systemic inflammation-based markers for predicting the prognosis of patients undergoing pancreaticoduodenectomy for pancreatic cancer.
    Utsumi M; Inagaki M; Kitada K; Tokunaga N; Yunoki K; Okabayashi H; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S
    PLoS One; 2024; 19(6):e0305844. PubMed ID: 38913646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Sarcopenia and Systemic Inflammatory Markers in Biliary Tract Cancer: A Retrospective Cohort Study.
    Utsumi M; Inagaki M; Kitada K; Tokunaga N; Yonoki K; Sakurai Y; Okabayashi H; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S
    J Gastrointest Cancer; 2024 Jun; 55(2):888-899. PubMed ID: 38403714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
    La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
    Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the skeletal muscle index and surgical outcomes of pancreaticoduodenectomy.
    Sui K; Okabayshi T; Iwata J; Morita S; Sumiyoshi T; Iiyama T; Shimada Y
    Surg Today; 2018 May; 48(5):545-551. PubMed ID: 29285616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter.
    Yamada S; Fujii T; Yabusaki N; Murotani K; Iwata N; Kanda M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Medicine (Baltimore); 2016 May; 95(18):e3582. PubMed ID: 27149487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
    Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
    J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma.
    Ikuta S; Aihara T; Yamanaka N
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e109-e114. PubMed ID: 30632282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
    Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
    Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
    Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
    [No Abstract]   [Full Text] [Related]  

  • 12. The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal adenocarcinoma.
    Terasaki F; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
    Updates Surg; 2021 Feb; 73(1):251-259. PubMed ID: 32410163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
    Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
    BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive values of sarcopenia and systemic inflammation-based markers in advanced hepatocellular carcinoma after hepatectomy.
    Utsumi M; Inagaki M; Kitada K; Tokunaga N; Yunoki K; Sakurai Y; Okabayashi H; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S
    Asian J Surg; 2024 Jul; 47(7):3039-3047. PubMed ID: 38388270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels: A Retrospective Multicenter Cohort Study.
    Aziz MH; Sideras K; Aziz NA; Mauff K; Haen R; Roos D; Saida L; Suker M; van der Harst E; Mieog JS; Bonsing BA; Klaver Y; Koerkamp BG; van Eijck CH
    Ann Surg; 2019 Jul; 270(1):139-146. PubMed ID: 29334554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
    Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
    World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of the sarcopenia and HALP score on postoperative outcomes in pancreatic cancer patients after pancreatoduodenectomy.
    Tazeoglu D; Benli S; Colak T; Apaydin FD
    Pancreatology; 2023 Aug; 23(5):530-536. PubMed ID: 37210304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between inflammation-based parameters and survival in metastatic pancreatic cancer.
    Turker S; Cilbir E; Guven DC; Karacin C; Yalcin S
    J Cancer Res Ther; 2021; 17(2):510-515. PubMed ID: 34121700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma.
    Peng P; Hyder O; Firoozmand A; Kneuertz P; Schulick RD; Huang D; Makary M; Hirose K; Edil B; Choti MA; Herman J; Cameron JL; Wolfgang CL; Pawlik TM
    J Gastrointest Surg; 2012 Aug; 16(8):1478-86. PubMed ID: 22692586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinically applicable muscular index predicts long-term survival in resectable pancreatic cancer.
    Delitto D; Judge SM; George TJ; Sarosi GA; Thomas RM; Behrns KE; Hughes SJ; Judge AR; Trevino JG
    Surgery; 2017 Apr; 161(4):930-938. PubMed ID: 27932030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.